Validity of ICD‐10‐CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapies-Reference-Cited by-同舟云学术

Validity of ICD‐10‐CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapies

Published:2021-05-03 Issue:7 Volume:30 Page:899-909
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Lo Re Vincent¹²^ORCID,Carbonari Dena M.²^ORCID,Jacob Jerry¹,Short William R.¹,Leonard Charles E.²,Lyons Jennifer G.³,Kennedy Adee³,Damon Jolene³,Haug Nicole³,Zhou Esther H.⁴^ORCID,Graham David J.⁴,McMahill‐Walraven Cheryl N.⁵,Parlett Lauren E.⁶,Nair Vinit⁷,Selvan Mano⁷,Zhou Yunping⁷,Pocobelli Gaia⁸^ORCID,Maro Judith C.³^ORCID,Nguyen Michael D.⁴

Affiliation:

1. Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

2. Center for Clinical Epidemiology and Biostatistics, Center for Pharmacoepidemiology Research and Training, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

3. Department of Population Medicine Harvard Medical School and Harvard Pilgrim Healthcare Institute Boston Massachusetts USA

4. United States Food and Drug Administration Silver Spring Maryland USA

5. Aetna, A CVS Health Company Blue Bell Pennsylvania USA

6. HealthCore Inc. Wilmington Delaware USA

7. Competitive Health Analytics Humana Healthcare Research, Inc. Louisville Kentucky USA

8. Kaiser Permanente Washington Health Research Institute Seattle Washington USA

Funder

U.S. Food and Drug Administration

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5253

Reference33 articles.

1. Biologic therapies for psoriasis. A systematic review;Boehncke WH;J Rheumatol,2006

2. Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis

3. Biological therapies in rheumatic diseases;Conti F;Clin Ter,2013

4. Infections associated with the use of tumor necrosis factor‐alpha inhibitors in psoriasis;Tan X;J Drugs Dermatol,2013

5. Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of clinical characteristics of lipodystrophy in the US adult population in a healthcare claims database;BMC Endocrine Disorders;2024-07-02

2. A Machine Learning Approach for Identifying People with Neuroinfectious Diseases in Electronic Health Records: Original Research Article (Preprint);2024-06-12

3. Hospitalizations for opportunistic infections following transplantation and associated risk factors: A national cohort study of Medicare beneficiaries;Transplant Infectious Disease;2024-06-09

4. Multiple morbidities are associated with serious infections in patients with rheumatoid arthritis;Seminars in Arthritis and Rheumatism;2024-04

5. Investigating the occurrence of autoimmune diseases among children and adolescents hospitalized for Mycoplasma pneumoniae infections;Frontiers in Immunology;2023-12-05